Debasish Sundi

Debasish Sundi, MD

  • Urology
  • Physician

Assistant Professor of Urology

Accepting new patients

Insurances We Accept


About Me

I am a urologist specializing in urologic oncology. I obtained my medical training at Northwestern University in Chicago and completed my surgical residency in urology at Johns Hopkins University in Baltimore. Subsequently, I completed a fellowship in urologic oncology at the University of Texas MD Anderson Cancer Center.

Treatment for urologic cancers can include multiple treatment choices, and I enjoy getting to know my patients and their priorities to determine the best care plans for each individual patient.

As a member of the Cancer Biology Program at the OSUCCC – James, my research focuses on exploring the functions of immune suppressive cells in the bladder cancer tumor microenvironment (in particular, myeloid derived suppressor cells) and identifying and blocking MDSC-specific signaling pathways. In so doin, my aim is to overcome therapeutic resistance to immune checkpoint blockade, which is a pressing clinical issue in bladder cancer. I am also exploring the use of beta-catenin inhibitors to modulate the tumor immune microenvironment and studying determinants of bladder cancer chemosensitivity.

In addition to performing research, which has been published in numerous peer-reviewed journals, I also serve as an editor for BMC Cancer and a reviewer for European Urology, Urologic Oncology, Journal of Urology and PLoS ONE. While I was at Johns Hopkins, I received the Frank L. Coulson, Jr., Award for Clinical Excellence, and my research in prostate cancer was recognized by ASCO in 2013 as one of the Clinical Cancer Advances of the year. While I was at MD Anderson, I received the Conquer Cancer Foundation of ASCO Merit Award and the William L. Pippin Endowed Fellowship for my work in bladder cancer research.

The OSUCCC – James is an incredible place. A direct benefit of the cutting-edge research and technology here is that I can offer my patients state-of-the-art treatment strategies and surgical options that maximize safety and precision. I am proud to be a member of The James, and to be part of the process that lifts oncology care to such heights is a true honor.

Procedures and Conditions I Treat

  • Minimally Invasive Surgical Procedures
  • Robotics
  • Bladder Cancer
  • Kidney Cancers
  • Prostate Cancers
  • Testicular Cancers
  • Urethral Cancers
  • Hematuria
  • Adrenal Cortex Cancers
  • Adrenal Gland Cancers
  • Urology

My Videos

Education and Training

Education History

Medical School

Northwestern University Feinberg School of Medicine, Chicago, IL
8/1/2004 - 5/20/2009


Johns Hopkins Medical Institute, Baltimore, MD

7/1/2009 - 6/30/2010


Johns Hopkins Medical Institute, Baltimore, MD

7/1/2010 - 6/30/2015


University of Texas MD Anderson Cancer Center, Houston, TX

7/1/2015 - 6/30/2017

Board Certification

American Board of Urology

Academic Information

My Department


More About My Work

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 10/25/2021, Dr. Sundi has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

  • Urogen
  • Arquer Diagnostics